Literature DB >> 22860199

Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.

Yong-Sok Lee1, Fabrice G Siméon, Emmanuelle Briard, Victor W Pike.   

Abstract

Eighteen kilodalton translocator protein (TSPO) is an important target for drug discovery and for clinical molecular imaging of brain and peripheral inflammatory processes. PK 11195 [1a; 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3-isoquinoline carboxamide] is the major prototypical high-affinity ligand for TSPO. Elucidation of the solution structure of 1a is of interest for understanding small-molecule ligand interactions with the lipophilic binding site of TSPO. Dynamic (1)H/(13)C NMR spectroscopy of 1a revealed four quite stable but interconverting rotamers, due to amide bond and 2-chlorophenyl group rotation. These rotamers have been neglected in previous descriptions of the structure of 1a and of the binding of 1a to TSPO. Here, we used quantum chemistry at the level of B3LYP/6-311+G(2d,p) to calculate (13)C and (1)H chemical shifts for the rotamers of 1a and for the very weak TSPO ligand, N-desmethyl-PK 11195 (1b). These data, plus experimental NMR data, were then used to characterize the structures of rotamers of 1a and 1b in organic solution. Energy barriers for both the amide bond and 2'-chlorophenyl group rotation of 1a were determined from dynamic (1)H NMR to be similar (ca.17 to 18 kcal/mol), and they compared well with those calculated at the level of B3LYP/6-31G*. Furthermore, the computed barrier for Z to E rotation is considerably lower in 1a(18.7 kcal/mol) than in 1b (25.4 kcal/mol). NMR (NOE) unequivocally demonstrated that the E rotamer of 1a is the more stable in solution by about 0.4 kcal/mol. These detailed structural findings will aid future TSPO ligand design and support the notion that TSPO prefers to bind ligands as amide E-rotamers.

Entities:  

Keywords:  PK 11195; TSPO; dynamic 1H/13C NMR; energetics; quantum chemistry; rotamer; structure; variable temperature

Mesh:

Substances:

Year:  2012        PMID: 22860199      PMCID: PMC3402376          DOI: 10.1021/cn3000108

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  23 in total

Review 1.  In vivo imaging of neuroinflammation.

Authors:  Annachiara Cagnin; Alexander Gerhard; Richard B Banati
Journal:  Eur Neuropsychopharmacol       Date:  2002-12       Impact factor: 4.600

2.  Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.

Authors:  C Braestrup; R F Squires
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands.

Authors:  S Selleri; F Bruni; C Costagli; A Costanzo; G Guerrini; G Ciciani; B Costa; C Martini
Journal:  Bioorg Med Chem       Date:  2001-10       Impact factor: 3.641

4.  Development of a unique 3D interaction model of endogenous and synthetic peripheral benzodiazepine receptor ligands.

Authors:  N Cinone; H D Hötje; A Carotti
Journal:  J Comput Aided Mol Des       Date:  2000-11       Impact factor: 3.686

Review 5.  PET tracers for the peripheral benzodiazepine receptor and uses thereof.

Authors:  Pernilla J Schweitzer; Brian A Fallon; J John Mann; J S Dileep Kumar
Journal:  Drug Discov Today       Date:  2010-08-26       Impact factor: 7.851

Review 6.  The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology.

Authors:  Senyang Lang
Journal:  Curr Med Chem       Date:  2002-08       Impact factor: 4.530

Review 7.  The peripheral benzodiazepine receptor: a promising therapeutic drug target.

Authors:  Sylvaine Galiegue; Norbert Tinel; Pierre Casellas
Journal:  Curr Med Chem       Date:  2003-08       Impact factor: 4.530

8.  N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.

Authors:  Giampaolo Primofiore; Federico Da Settimo; Sabrina Taliani; Francesca Simorini; Maria Paola Patrizi; Ettore Novellino; Giovanni Greco; Enrico Abignente; Barbara Costa; Beatrice Chelli; Claudia Martini
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

9.  Structure-activity relationships in carboxamide derivatives based on the targeted delivery of radionuclides and boron atoms by means of peripheral benzodiazepine receptor ligands.

Authors:  Andrea Cappelli; Gal la Pericot Mohr; Andrea Gallelli; Germano Giuliani; Maurizio Anzini; Salvatore Vomero; Massimo Fresta; Patrizia Porcu; Elisabetta Maciocco; Alessandra Concas; Giovanni Biggio; Alessandro Donati
Journal:  J Med Chem       Date:  2003-08-14       Impact factor: 7.446

Review 10.  Visualising microglial activation in vivo.

Authors:  Richard B Banati
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

View more
  6 in total

1.  Z and E rotamers of N-formyl-1-bromo-4-hydroxy-3-methoxymorphinan-6-one and their interconversion as studied by 1H/13C NMR spectroscopy and quantum chemical calculations.

Authors:  Agnieszka Sulima; Kejun Cheng; Arthur E Jacobson; Kenner C Rice; Klaus Gawrisch; Yong-Sok Lee
Journal:  Magn Reson Chem       Date:  2012-12-11       Impact factor: 2.447

2.  Synthesis and Screening in Mice of Fluorine-Containing PET Radioligands for TSPO: Discovery of a Promising 18F-Labeled Ligand.

Authors:  Fabrice G Siméon; Jae-Hoon Lee; Cheryl L Morse; Ian Stukes; Sami S Zoghbi; Lester S Manly; Jeih-San Liow; Robert L Gladding; Rachel M Dick; Xuefeng Yan; Sabrina Taliani; Barbara Costa; Claudia Martini; Federico Da Settimo; Sabrina Castellano; Robert B Innis; Victor W Pike
Journal:  J Med Chem       Date:  2021-11-10       Impact factor: 7.446

3.  Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging.

Authors:  François Guérard; Yong-Sok Lee; Raphaël Tripier; Lawrence P Szajek; Jeffrey R Deschamps; Martin W Brechbiel
Journal:  Chem Commun (Camb)       Date:  2012-12-19       Impact factor: 6.222

4.  Translocator protein ligands based on N-methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development.

Authors:  Chad Brouwer; Kimberly J Jenko; Sami S Zoghbi; Cheryl L Morse; Robert B Innis; Victor W Pike
Journal:  Eur J Med Chem       Date:  2016-08-25       Impact factor: 6.514

Review 5.  Insight into the Structural Features of TSPO: Implications for Drug Development.

Authors:  Jean-Jacques Lacapere; Luminita Duma; Stephanie Finet; Michael Kassiou; Vassilios Papadopoulos
Journal:  Trends Pharmacol Sci       Date:  2019-12-18       Impact factor: 14.819

6.  Structure of the mitochondrial translocator protein in complex with a diagnostic ligand.

Authors:  Lukasz Jaremko; Mariusz Jaremko; Karin Giller; Stefan Becker; Markus Zweckstetter
Journal:  Science       Date:  2014-03-21       Impact factor: 47.728

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.